Current opinion in refractory and/or unexplained chronic cough DOI
Stephanie Misono, Carolyn K. Novaleski

Current Opinion in Otolaryngology & Head & Neck Surgery, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 5, 2024

Purpose of review Otolaryngologists are vital to successfully managing chronic cough in adults. This presents updates regarding rapidly evolving concepts cough. Recent findings Significant growth is occurring research, strengthening the evidence its major psychosocial impacts. Elucidation neural underpinnings normal and abnormal within both peripheral central nervous systems highlight previously underappreciated complexity clinical practice recommendations emphasize personalized treatment approaches through addressing treatable traits Investigations ongoing better distinguish subgroups, multiple types important outcome measures being characterized. Newer research about encompasses pharmacologic nonpharmacologic interventions, including oral inhaled medications, superior laryngeal nerve blocks, behavioral therapy. Summary As knowledge adults continues expand practice, otolaryngologists can continue raise awareness role larynx promote multidisciplinary collaborations. In coming years, more options will likely emerge for

Language: Английский

Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID DOI Creative Commons

Jun-Won Seo,

Seong Eun Kim, Yoonjung Kim

et al.

Infection and Chemotherapy, Journal Year: 2024, Volume and Issue: 56(1), P. 122 - 122

Published: Jan. 1, 2024

"Long COVID" is a term used to describe condition when the symptoms and signs associated with coronavirus disease 2019 (COVID-19) persist for more than three months among patients infected COVID-19; this has been reported globally poses serious public health issue. Long COVID can manifest in various forms, highlighting need appropriate evaluation management by experts from fields. However, due lack of clear clinical definitions, knowledge pathophysiology, diagnostic methods, treatment protocols, it necessary develop best standard guidelines based on scientific evidence date. We developed guideline diagnosing treating long analyzing latest research data collected start COVID-19 pandemic until June 2023, along consensus expert opinions. This provides recommendations diagnosis that be applied practice, total 32 key questions related COVID. The should comprehensive, including medical history, physical examination, blood tests, imaging studies, functional tests. To reduce risk developing COVID, vaccination antiviral during acute phase are recommended. will revised there reasonable updates availability new

Language: Английский

Citations

22
The Course of COVID-19 and Long COVID: Identifying Risk Factors among Patients Suffering from the Disease before and during the Omicron-Dominant Period DOI Creative Commons
Mateusz Babicki, Damian Kołat, Żaneta Kałuzińska‐Kołat

et al.

Pathogens, Journal Year: 2024, Volume and Issue: 13(3), P. 267 - 267

Published: March 20, 2024

SARS-CoV-2 has acquired many mutations that influence the severity of COVID-19's course or risk developing long COVID. In 2022, dominant variant was Omicron. This study aimed to compare COVID-19 in periods before and during dominance Omicron variant. Risk factors for COVID were also assessed. based on stationary visits patients after follow-up assessments 3 months. Clinical symptoms, comorbidities, vaccination status evaluated 1967 patients. Of analyzed group, 1308 (66.5%) affected by period dominance. The prevalence significantly lower among group (47.7% vs. 66.9%,

Language: Английский

Citations

6
Clinical outcomes of persistent cough following coronavirus disease 2019 infection: a 1-year retrospective cohort study DOI Open Access
Sang Pyo Lee, Sung‐Yoon Kang

Asia Pacific Allergy, Journal Year: 2025, Volume and Issue: unknown

Published: March 20, 2025

Background: Cough is one of the multiple prolonged symptoms observed in patients who had coronavirus disease 2019 (COVID-19) infection. Objective: We assessed clinical outcomes and identified factors contributing to cough persistence post-COVID-19. Methods: This retrospective cohort study included adults visited a specialist clinic between 2022 2023. All participants underwent systematic investigation treatment for persistent cough. was at 2- 12-month follow-ups. Participants were classified as having if they current troublesome follow-ups, severity visual analog scale (VAS) score change below 30. Results: Sixty-six (mean age 48.7 years; 72.7% women) analyzed divided into 2 groups: (33.3%) remitted (66.7%). The group significantly higher prevalence abnormal laryngeal sensation, sputum production, breathing difficulty, airway eosinophilia; their VAS changes months also lower. Multivariate analyses indicated associations 1 year such eosinophilia (adjusted odds ratio [aOR], 6.78), sensation (aOR, 6.42), low reduction 1.05). Conclusion: Persistent remained significant issue one-third after COVID-19. features commonly chronic present those have experienced COVID-19, which contributed These findings underscore need assessment tailored strategies effectively manage

Language: Английский

Citations

0
AI and IoT for CT-Based COVID-19 Diagnosis DOI
Jiaji Wang, Jian‐Ming Li, J. M. Górriz

et al.

Published: Jan. 1, 2025

Language: Английский

Citations

0
Relevant factors associated with the development of chronic cough after recovery from COVID-19 DOI
Yoshihiro Kanemitsu, Kensuke Fukumitsu, Akio Niimi

et al.

Respiratory Investigation, Journal Year: 2024, Volume and Issue: 62(2), P. 269 - 276

Published: Jan. 23, 2024

Language: Английский

Citations

2
Clinical characteristics and effects of inhaled corticosteroid in patients with post-COVID-19 chronic cough during the Omicron variant outbreak DOI Creative Commons

Panpan Xie,

Yue Zhang,

Wenkai Niu

et al.

BMC Pulmonary Medicine, Journal Year: 2024, Volume and Issue: 24(1)

Published: March 27, 2024

Abstract Background Chronic cough is a common symptom in patients post the coronavirus disease 2019 (COVID-19). In this study, we aimed to investigate efficacy of inhaled corticosteroids (ICS) and clinical characteristics with post-COVID-19 chronic during Omicron era. Methods An ambispective, longitudinal cohort study was conducted that included who attended respiratory clinic at our hospital between January 1, 2023, March 31, 2023 complaint persistent lasting more than 8 weeks. At 30 60 days after first visit for cough, enrolled were prospectively followed up. We compared changes symptoms pulmonary function receiving ICS treatment (ICS group) those not (NICS two visits. Results A total 104 group, n = 51; NICS 53). The most accompanying sputum (58.7%, 61/104) dyspnea (48.1%, 50/104). Seventy-one (82.6%, 71/86) had airway hyperresponsiveness, 49 (47.1%, 49/104) newly diagnosed asthma. Most (95.2%, 99/104) exhibited improvement visit. parameters group significantly improved baseline values ( P < 0.05), FEV 1 /FVC greater 0.003) days. Conclusions Severe acute syndrome coronavirus-2 (SARS-CoV-2) may contribute pathogenesis asthma, which could be underlying cause infection. Post-COVID-19 era often accompanied by sputum, dyspnea, hyperresponsiveness. did have significant impact on management cough; however, it can improve impaired lung these individuals.

Language: Английский

Citations

2
A Physiotherapy Framework to Managing Long COVID: A Clinical Approach DOI
S. Peirce, Mitchell A. Taylor,

Talia Pollok

et al.

Cardiopulmonary Physical Therapy Journal, Journal Year: 2024, Volume and Issue: 36(1), P. 19 - 29

Published: Dec. 30, 2024

Purpose: Individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes disease 2019 (COVID-19), can experience ongoing, often debilitating symptoms after infection known as Long COVID (LC). LC has profound medical, social, and economic consequences worldwide. Prevalence estimates vary, but it is estimated 10% to 35% of people SARS-CoV-2 develop LC. The World Health Organization endorses physiotherapy a vital component in symptom management stabilization. Cardiorespiratory physiotherapists are involved patients phenotypes such post-exertional malaise/post-exertional exacerbation, post-COVID interstitial lung disease, dysautonomia, breathing pattern disorders, chronic cough. However, specific guidance lacking regarding assessment safe intervention strategies. In this review, we describe relevant pathophysiology condition, report common clinical phenotypes, propose framework for

Language: Английский

Citations

1
A treatable traits approach for asthma in a post-COVID era DOI
Yuto Hamada, Eleanor C. Majellano, Peter G. Gibson

et al.

Published: June 27, 2024

As a novel respiratory viral infection, coronavirus disease 2019 (COVID-19) has influenced asthma in unpredictable ways. In the post-COVID era, there is need to review care and new challenges opportunities that are presented. Long COVID complex syndrome arisen. Treatable traits (TTs) have already been developed address can be adapted manage long COVID. Consumers seeking more information on answers what expect with dual diagnosis of COVID-19. People identify strong for research into asthma. Completion national survey (n = 593) resulted list themes. From these, participants prioritized 10 Among top priorities, theme was ranked as second priority overall rank list. Addressing these issues potential improve global health.

Language: Английский

Citations

0
Incidence of new-onset bronchial asthma in post-COVID patients with persistent respiratory symptoms DOI Creative Commons

Priyanka Singh,

Amit Singh Vasan, Nitin Balram Ahuja

et al.

The Journal of Association of Chest Physicians, Journal Year: 2024, Volume and Issue: 12(4), P. 174 - 179

Published: Oct. 1, 2024

Background: The current coronavirus disease 2019 (COVID-19) pandemic is an ongoing global healthcare challenge that has caused morbidity and mortality at unprecedented levels. Studies have estimated approximately 10% of all patients who recovered from COVID-19 are suffering persistent symptoms cough, dyspnea, fatigue over months after the acute infection. Many reported airway post-COVID. Since post-COVID pulmonary complications evolving challenging, a study was carried out to assess new-onset asthma in adults. Objectives: To incidence following Methods: A prospective observational including adult admitted or treated on patient department (OPD) basis for out. All follow-up with (cough, wheezing, breathlessness, chest tightness) no prior diagnosed obstructive/restrictive were included followed up duration 01 years. New-onset based symptomatology assessed as per Global Initiative Asthma guidelines. Results: Among 411 post-COVID-19, 9.4% ( n = 97) developed bronchial follow-up. Conclusion: patients’ post-COVID-19 not uncommon, detailed evaluation instrumental instituting timely correct therapy providing symptomatic relief patients.

Language: Английский

Citations

0
MỘT SỐ NGUYÊN NHÂN GÂY HO KÉO DÀI Ở BỆNH NHÂN SAU KHI NHIỄM COVID 19 DOI Open Access

Thị Thu Hương Bùi

Tạp chí Y học Việt Nam, Journal Year: 2024, Volume and Issue: 533(1B)

Published: Jan. 5, 2024

Mục tiêu: 1. Các nguyên nhân có thể gây ho ở bệnh sau khi nhiễm Covid 19; 2. Tỷ lệ bị kéo dài 19. Thiết kế nghiên cứu: quan sát mổ tả 1875 trường hợp. Kết quả: Nguyên gặp Covid: Hen: 91 hợp (4.85%), COPD 139 (7.41%), Viêm mũi dị ứng: 239 (12.75%), Trào ngược: 477 (25.44%). Do các phổi: lao, viêm phổi kẽ, nấm giãn phế quản, u chiếm 263 (14.03%). đường hô hấp trên: 97 (5.17%). Ho do covid 373 (19.89%). luận: 19 19% COvid Còn rất nhiều khác BN 19: trào ngược, hen, xoang ứng, lao… chúng ta cần chú trọng tìm để điều trị cho nhân.

Citations

0